Long-Term Antipsychotic Pediatric Safety Trial (Laps)
Posted Date: Nov 20, 2019
- Investigator: Luis Patino Duran
- Specialties: Adolescent Psychiatry/Psychology, Bipolar Disorder, Psychiatry/Psychology
- Type of Study: Observational/Survey
This study is designed evaluate the weight changes associated with multi-year risperidone and aripiprazole therapy in children ages 3- <18 years. This study will also provide insights into the overall long-term safety and the quality of life effects of both drugs.
Use Of Either Risperidone Or Aripiprazole Mono-Antipsychotic Therapy As Prescribed By Participant’S Prescribing Medical Provider.
Schizophrenia, Bipolar Disorders, Irritability Associated With Autistic Disorder
For More Information: